Jci_page_head_homepage_01 Jci_page_head_homepage_02
Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay
Published in Volume 116, Issue 12
J Clin Invest. 2006; 116(12):3258–3265 doi:10.1172/JCI29602
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
Cytotoxicity of islet-infiltrating T cells as assessed by a standard 4-hour 51Cr release assay.

(A) T cells expanded from islets of NOD-IGRP mice (n = 4) or control littermates (n = 4) were assessed for cytotoxicity against P815 cells loaded with the indicated peptides. (B) T cells expanded from islets of nontransgenic NOD mice were sorted by flow cytometry on the basis of whether they bound or did not bind H-2Kd IGRP206–214 tetramer. Both tetramer-positive and tetramer-negative T cells were able to kill β cells from NOD mice. (C) T cells expanded from islets of NOD-IGRP (n = 5) or NOD mice (n = 8) were assessed for cytotoxicity against P815 cells loaded with indicated peptides.